InsidersTradesSigma
Total declarations
Companies
▲ Purchases (13 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
13
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+8.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Johnson David Michael, Director. Officer active across 2 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 24 disclosures have been logged. Breakdown: 13 buys · 1 sell. Total volume traded: €1.9m. History available since 4 June 2021. The latest transaction was filed on 17 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Johnson David Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
15,000 sharesCommon StockSEC:0001193125-26-271168:0
57,603 shares0Common StockSEC:0001725160-25-000133:0
13,000 shares0Common StockSEC:0000950170-25-087890:0
20,000 shares@ US$4.906.0% of flowCommon StockSEC:0000950170-25-075412:0
Canonical exit: 14 Aug 2025 (T+90)
10,500 shares0Common StockSEC:0000950170-24-076707:0
48,429 shares0Common StockSEC:0001725160-24-000141:0
17,000 shares@ US$9.87922.1% of flowCommon StockSEC:0001725160-23-000201:0
Canonical exit: 8 Feb 2024 (T+90)
76,000 shares@ US$7.1734.7% of flowCommon StockSEC:0000950170-23-062214:0
Canonical exit: 5 Feb 2024 (T+90)
13,500 shares@ US$8.27137.3% of flowCommon StockSEC:0000950170-23-052244:0
Canonical exit: 1 Jan 2024 (T+90)
19,059 shares0Common StockSEC:0001725160-23-000146:0
300 shares@ US$10.000.2% of flowCommon StockSEC:0000899243-23-001324:0
Canonical exit: 5 Apr 2023 (T+90)
2,000 shares@ US$9.751.3% of flowCommon StockSEC:0000899243-22-039594:0
Canonical exit: 28 Mar 2023 (T+90)
5,000 shares@ US$12.374.0% of flowCommon StockSEC:0000899243-22-038695:0
Canonical exit: 1 Mar 2023 (T+90)
3,000 shares@ US$15.040.0050% mcap100.0% of flowCommon StockSEC:0000899243-22-022456:0
Canonical exit: 8 Sept 2022 (T+90)
10,000 shares@ US$15.049.7% of flowCommon StockSEC:0000899243-22-022456:2
Canonical exit: 8 Sept 2022 (T+90)
7,000 shares@ US$13.996.4% of flowCommon StockSEC:0000899243-22-022456:3
Canonical exit: 11 Sept 2022 (T+90)
20,000 shares@ US$13.9918.3% of flowCommon StockSEC:0000899243-22-022456:5
Canonical exit: 11 Sept 2022 (T+90)
3,000 shares@ US$15.042.9% of flowCommon StockSEC:0000899243-22-022456:1
Canonical exit: 8 Sept 2022 (T+90)
7,000 shares@ US$13.996.4% of flowCommon StockSEC:0000899243-22-022456:4
Canonical exit: 11 Sept 2022 (T+90)
24,871 shares0Common StockSEC:0001725160-22-000121:0
7,500 shares0Common StockSEC:0001725160-21-000242:0
139,672 shares0Common StockSEC:0000899243-21-042361:0
4,892 shares@ US$65.950163.8% of flowCommon StockSEC:0001725160-21-000197:0
5,000 shares0Common StockSEC:0001725160-21-000142:0
24 of 24 declarations
About Johnson David Michael
Johnson David Michael is Administrateur. He has 24 filings in total, and across the 24 sampled filings, buys total 1623659 EUR and sells total 277686 EUR, between 2021-06-08 and 2026-06-15. His filings concern Aura Biosciences, Inc. and Zentalis Pharmaceuticals, Inc.
